Abstract
The nephrotic syndrome is a rare complication of Hodgkin's disease. The majority of the cases do not respond to corticosteroids but are cured by the treatment of the lymphoma. We describe a patient with a nephrotic syndrome at the time of diagnosis of mixed cellularity Hodgkin's disease and the resolution of this nephrotic syndrome by MOPP-ABV chemotherapy.
MeSH terms
-
Adult
-
Antibiotics, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents, Alkylating / administration & dosage
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bleomycin / administration & dosage
-
Doxorubicin / administration & dosage
-
Hodgkin Disease / complications*
-
Hodgkin Disease / diagnostic imaging
-
Hodgkin Disease / drug therapy
-
Humans
-
Male
-
Mechlorethamine / administration & dosage
-
Nephrotic Syndrome / etiology*
-
Nephrotic Syndrome / therapy
-
Paraneoplastic Syndromes / etiology*
-
Paraneoplastic Syndromes / therapy
-
Prednisone / administration & dosage
-
Procarbazine / administration & dosage
-
Tomography, Emission-Computed
-
Tomography, X-Ray Computed
-
Vinblastine / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Antibiotics, Antineoplastic
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents
-
Antineoplastic Agents, Alkylating
-
Antineoplastic Agents, Hormonal
-
Antineoplastic Agents, Phytogenic
-
Bleomycin
-
Procarbazine
-
Mechlorethamine
-
Vincristine
-
Vinblastine
-
Doxorubicin
-
Prednisone